Authorized Representative: Higher Liability affecting Agreement

in Blog

Ever since the introduction of the mandatory requirement of an European Authorized Representative (EAR) for any manufacturer based outside of the European Union looking to introduce products to the European market under General Product Safety Directive 2001/95/EC, many manufacturers have been expressing concerns on what the accepted limits, boundaries, and responsibilities are in the relationship between manufacturer and EAR. One of the most fundamental aspects to understand when working with a European Authorized Representative to bring your products to the European Market is knowing what obligations fall upon you as a manufacturer and what information and documentation must be supplied to and handled by your EAR. Understanding the basics in this way can help keep liability on the correct party and avoid unnecessary complications in the relationship which may be problematic down the line. Read more

Heavy Metals in Cosmetics

in Blog

The use of heavy metals in cosmetic products has always been a complicated issue around the world and remains so to this day. From a technical standpoint, the use of any kind of heavy metal in a cosmetic product is strictly banned inside the European Union under EU Regulation 1223/2009. The regulation, designed to harmonize standards throughout the EU and to ensure greater levels of consumer safety, set out a number of guidelines for manufacturers to adhere to, including forbidding the use of heavy metals (like arsenic, lead, tin, chlorine, cobalt, mercury, and zinc) and introducing mandatory safety reporting to ensure products are in compliance. For manufacturers of cosmetic products, this can sound like bad news, however there are things that can be done to bring products into compliance and for many products there is a little leeway given. Read more

Aesthetic Products Under New Medical Device Regulation

in Blog

Changes brought on by the recently adopted Medical Device Regulation, Regulation 2017/745, have been a cause of concern for some manufacturers of products used within the medical industry. Introduced on 5th April 2017, the new medical device regulation widened the scope of what can be classed as a ‘medical device’, leaving many manufacturers questioning what implications this has for their products or devices and how this will affect the compliance process. Read more

Implementing a GMP for Cosmetics

in Blog

A clear and transparent set of Good Manufacturing Practices is a legal requirement under European regulation EC 1223/2009 for any manufacturer of cosmetic products looking to release their products onto the European Market. Installed in order to ensure harmonization with consumer health and safety requirements inside the European Union, Regulation 1223/2009, in connection with ISO 22716:2007, lays out a number of guidelines all manufactures must adhere to. Factors falling into the Good Manufacturing Practices (GMP) process can include things like product control, shipment, and storage, as well as proper waste management and recall procedures – many of which are included in a cosmetic product’s Product Information File (PIF).

In many cases this can often cause undue stress for manufacturers who find themselves asking when they should begin the compliance process and how they can prove their compliance once the process is completed, sometimes questioning through lack of regulatory knowledge whether, if at all, their product is in line with ISO guidelines. It may relieve some to hear that while compliance with and proof of GMP is mandatory, there are several ways that evidence can be provided, and while compliance with ISO guidelines may be the most straightforward way, there are other options.

As stated above, evidence of Good Manufacturing processes can be provided in a number of ways including self-declaration as a manufacturer, or by having a third-party issue a certificate following an on-site audit. A number of the following factors must be taken into consideration in the proof of GMP:

  • Manufacturer’s staff
  • Premises
  • Equipment
  • Raw Materials
  • Manufacturing Process
  • Waste Management
  • Change Management
  • Complains and Recalls
  • Auditing and Quality Control
  • Documentation
  • Storage


This is only a brief outline of some of the factors covered under GMP, others include guidelines for subcontracting, treatment of product deviations, control of the finished product, and more. As is the case with many European cosmetic regulations, adherence and proof of GMP within Europe is presumed, and the onus to be compliant is entirely on the manufacturer.

For more information on how to implement best GMP, to get a quote on our Responsible Person or advisory Services, or to get in touch with our team of European legislative experts, contact us today!

Game Plan for Upgrading Compliance under Medical Device Regulation 2017/745

in Blog

Since the introduction of EU Medical Device Regulation 2017/745, manufacturers have been rushing to prepare for it taking full effect on 25th May 2020. The best advice is to start getting ready for the transition now to ensure a smooth process with no negative effects. The first step in getting ready for MDR 2017/745 is understanding what it is and what requirements it has for manufacturers of medical devices. With that in mind, we put some information together to help clear the process up! Read more

What are the New Approach Directives?

in Blog







For manufactures and distributors of all types of products looking to enter the European market, it can sometimes feel like there is so much to know about compliance, standards, and expectations inside the EU. Guidelines for market placement and post-placement procedures can often feel unclear to some, especially when it comes to what we call the ‘New Approach’ directives. With that in mind, in this blog we’re going to provide a little insight into just what these directives are and how they work.

In the most simple sense, the New Approach directives are a series of legislative requirements that are in place to ensure ultimate product safety on the European market, to protect both consumer and manufacturer. First adopted by the European Union in 1985, the directives are most easily recognisable by their legislating for the requirement of a CE Mark (for products) and an Authorized Body (for manufacturers), also called for under the New Approach directives is the instating of Notified Bodies as invigilators for pre-market approval and surveillance. Read more

Can I use my existing packaging for the EU Market?

in Blog

One of the most common recurring questions from manufacturers or distributors looking to enter the European Market, especially in the cosmetics industry, is “Can I use my existing packaging in the EU?”. The answer to this isn’t as straight forward as one might think and must be handled with care to avoid the product (or range of products) in question being removed from the market. Read more

Incidents defined under the new Medical Device Regulation

in Blog

A large number of new requirements in regard to the safety of medical devices were brought into effect with the recent EU Regulation 2017/745. One important such practice was the requirement for an established process to be set in place for reacting to and reporting ‘incidents’ involving medical devices and how manufacturers or distributors in Europe should put them in place effectively. To give a greater level of clarity on the issue, we are going to examine the definition of ‘incident’ as outlined in MDR 2017/745 as well as some of the points most important for manufacturers operating in the European market to know. Read more

My product has been found to be non-compliant – now what?

in Blog

Full compliance is vital for all cosmetic products that are seeking to enter or have already been placed on the European Market. Under European Cosmetics Regulation 1223/2009, the onus falls to the manufacturer or distributor to ensure each product they have introduced to the market is fully compliant not only with Regulation 1223/2009 but all other applicable regulations or directives. It is for this reason that those responsible should be aware of the consequences of non-compliance, and in the event of such an occurrence, how to deal with the situation. Read more

FDA vs. EU compliance under the new Medical Device Regulation

in Blog

The recently adopted Medical Device Regulation 2017/745, set as an amendment to EU Directive 93/42/EEC, laid out some essential health and safety requirements as regards compliance paths for manufacturers with medical devices looking to enter the European Market. Regulations and directives like these create Harmonized Standards which ensure all products in a given market place are safe for consumer use. However, as one passes from one market place to another, they might find that some paths of product compliance may vary. In this blog, we are going to outline some of the main points introduced by MDR 2017/745 to help explain some of the commonalities and differences between the FDA system in the USA and the system introduced by the European Commission in Europe in an effort to point out how some compliance paths may vary from region to region, and as a result, why it is so important to be aware of all compliance related issues relevant to your product. Read more

Red and Blue Light Therapy Devices and EU Compliance

in Blog

As the demand for light therapy devices grows, and the industry along with it, widespread call for regulation within the field has been made. Until previously, many light therapy devices have been unable to be classified or covered by any particular European regulation or directive. However, earlier this year, EU Medical Device Regulation 2017/745 entered into force, and with it came an amendment to Directive 93/42/EEC introducing changes for light therapy devices making certain claims. Read more

Making Organic & Natural Claims in Europe

in Blog

Trends have emerged over the last decade, in both the global and European Market, of consumers opting for cosmetic products that describe themselves as “organic”, “natural”, “sustainably sourced”, or “green”. These products, generally, claim to be low in chemically produced ingredients and more holistic in terms of cosmetic and environmental side effects. While this represents a positive shift in consumer mindset, it has caused a need for much regulatory and compliance-related reflection brought on by an increasing number of products seeking to advertise themselves as “natural” or “organic” as a result. Read more

Period After Opening Vs Expiration Date

in Blog

By  Davide Turchi – RA/QA Consultant

European Cosmetics Regulation EC 1223/2009 set out many mandatory guidelines and requirements for labeling and clearly communicating relevant safety information on cosmetic products. Each of these guidelines and cosmetic requirements (read more about the full list of requirements here), labeling included, must be strictly adhered to by manufacturers for any cosmetic product seeking to enter the European Market. Two important inclusions under the regulation that some manufacturers and consumers alike often find confusing are the Expiration Date and the Period After Opening (PAO). In this article we will shed some light on the differences between both of these mandatory labeling requirements and how Regulation EC 1223/2009 affect them. Read more

What is RAPEX

in Blog

Keeping track of data relating to all products available on the European Market can be very difficult to say the least, and yet, from a compliance and regulatory standpoint, it’s a very, very important part of ensuring all products circulating throughout Europe are safe for use. For bodies on all parts of the supply chain (from manufacturers to distributors, retailers to consumers, and even the European Commission itself), having up-to-date access to information regarding products’ compliance status is paramount. In an effort to facilitate this efficient movement of information, the RAPEX system was created. Read more

I notified my own products within the CPNP

in Blog

First introduced in January 2012, the Cosmetics Products Notification Portal (CPNP) is a European notification platform intended for submitting technical compliance related information regarding cosmetic products to conveniently convey to any relevant competent authorities that a cosmetic product is fully compliant with all concerned directives and regulations. Created under Regulation 1223/2009/EC, the CPNP aims at harmonizing cosmetics products within all EU Member States (including four EFTA countries) covered by the legislation. The regulation also makes CPNP notification a mandatory part of the compliance process for all cosmetic products seeking to enter the European Market. Read more

Already selling in Europe without a problem

in Blog

In many cases it is possible for some products to have found their way onto the European Market without having undergone the proper Compliance screening processes or having been awarded an official CE Marking. In these types of cases, manufacturers may well feel that there is no real pull factor to encourage them to seek CE certification and that the onus to request information on such issues falls outside the realm of their responsibility. This, of course, is not the case. The most important thing to note in instances like these is simply that a product’s presence on the market does not imply compliance. Read more

What is COSMOS Certification?

in Blog

Within the wide world of cosmetics, many different bodies exist with to the purpose of regulating the quality and standards for a large variety of products. Manufacturers or distributors seeking to enter certain markets, advertise in certain ways, or make certain claims about their cosmetics products sometimes encounter different bodies from whom they will need to receive compliance certification in order to assure distributors, markets and consumers of their legitimacy and safety. These are called ‘Authorised Bodies’. In the case of organic or natural cosmetic products in Europe, that authorized body is known as COSMOS. Read more

Updated Quality Management Requirements for OBL Manufacturers

in Blog

A number of key changes in requirements for quality management processes that may affect several Original Brand Labelers (OBLs) have been introduced recently. The updates, affecting those operating in the fields of Medical Devices and In-Vitro Diagnostic Devices, mainly concern OBLs’ current auditing system and quality management practices – extending the boundaries and giving clearer, stricter guidelines for both.

For the sake of clarity it is worth outlining that the definition of an OBL is generally accepted as any company that receives equipment made by a manufacturer with the intent of repackaging or incorporating that equipment under its own brand name. As such, an OBL is generally the body expected to place a product on the market under its own name, brand, or trade name.

As part of the updated requirements, OBLs are obligated to facilitate a quality management system (QMS) that adheres to each requirement laid out in the relevant directive – MDD 93/42/EEC in the case of OBLs working with medical devices. It is worth noting that while this doesn’t necessarily mean that a fully compliant ISO13485 system is mandatory in each case, it would certainly simplify processes in terms of harmonised standards.

Included in the new QMS requirements, the following (at a minimum) must be included in a product’s documentation (to be assessed during annual audits):

  • Traceability data
  • Regulatory requirements (market surveillance, vigilance, etc.)
  • Quality control data
  • Organisational structure for the company (including roles and responsibilities)
  • Quality objectives
  • Complaints
  • Internal audit information and documentation
  • Management review
  • Client communications and order-processing
  • Manufacturing processes (including performance testing and non-conformity information)
  • Corrective and preventative actions taken by the company
  • Purchasing from and control of related parties (including Original Equipment Manufacturers and other suppliers)


OBLs dealing in Class IIb and Class III medical devices are also obligated to provide design processes within the updated quality management system documentation. It is important to note that OBLs are obligated to carry out each of these processes themselves and cannot delegate to an Original Equipment Manufacturer (OEM) or any other third party. Failure to do so can result in a range of consequences for the OBL, including loss of CE certification or destruction of the product in question.

In addition to regular annual audits, a series of unannounced audits will also be required by the new updates. These audits will be carried out at the place(s) where the devices in question are manufactured – in most cases these may be the premises of an OEM. The responsibility for all audit costs falls onto the OBL as the body responsible for introducing the product to the European Market. It is important to also note that non-compliance or refusal to undergo the full unannounced auditing process (by either the OEM or the OBL) can result in a suspension of the manufacturer’s CE certification.

For more information on the new updates to quality management requirements, to learn about Obelis’ CE Marking and Authorized Representative services, or for advice on compliance with European directives, contact our team of regulatory experts today!

Why Don’t Retailers Request Proof of Compliance?

in Blog

The path to compliance can often be a long and confusing one full of roadblocks for manufacturers and distributors uninitiated to the intricacies of the process. In the case of manufacturers working within the boundaries of the General Product Safety Directive (GPSD 2001/95/EC), whose products would generally be consumer orientated and therefore open not just to the European Market but the general European public at large, many detrimental assumptions or errors due to lack of experience or knowledge can be made which can lead to any degree of safety risk to users of their product. Read more

Can I Piggyback on my OEMs CE Certificate?

in Blog

In many ways, a CE Certificate is a passport to the European Market for any medical device. It provides definitive proof that manufacturers and their products adhere to all European compliance regulations and that all standards have been met at each stage of the production process. The certificate itself ensures only the highest quality, safest products reach the EU marketplace. It is, however, not just a badge of honour for manufacturers and products, it’s also a mandatory requirement for distribution and sales within Europe. This is true for both Original Equipment Manufacturers (OEMs) and Original Brand Labelers (OBLs). Read more

What is changing for IVD Classification under the new IVD Regulation?

in Blog

Many manufacturers may very well already be feeling the benefits of the new EU IVD Regulation 2017/746. Approved on April 5th of this year, and in force as of May 26th, the new regulation did much to tackle previous issues felt by manufacturers and distributors alike struggling to introduce their IVD devices to the European Market on account of homogeneity in the scope of device classification. Read more

Consequences of Non-Compliance

in Blog

Full adherence to all compliance-related matters is a hugely important part of introducing a product to the European Market – or indeed maintaining its position there. Each category of CE Marking certifiable product has its own set of regulations or directives, from medical devices to personal protective equipment to toys, and electromagnetic devices to construction products and motor vehicles.

The onus is entirely on the manufacturer to demonstrate that their product is in full compliance with the relevant essential EU directives and regulations – all of which must be adhered to in advance of a CE marking being initially affixed. Some directives also call for the appointment of a Notified Body to assess compliance or product-specific issues, though this is generally only the case with high risk or safety critical products. Read more

Can Safety Assessment be done in a lab outside of the EU?

in Blog

The Safety Assessment procedure is a crucially important part of the cosmetics compliance process for all manufacturers and distributors seeking to introduce a cosmetic product to the European Market for the first time. Under Annex 1 of European Cosmetics Regulation EC 1223/2009, the safety assessment makes up an entire part (Part B) of the Product Information File – without either of which a product cannot be brought to any European member states.

When it comes to where and how the safety assessment procedure can be carried out, there are a couple of guidelines and conditions laid out in regulation EC 1223/2009 which can help manufacturers more easily navigate the compliance process. In this blog, we will outline the most important issues and conditions for manufacturers and distributors who wish to carry out their safety assessments outside the boundaries of a laboratory inside the European Union.

Read more

Can I use a CE Mark if I don’t sell in the EU?

in Blog

A product’s CE marking is seen as the gold-standard in industry and consumer market quality in Europe. It stands as a mark of highest quality, rigorous testing, and to-the-letter compliance with strict health and safety codes and regulations. As a result of this, it is a huge testament to any product bearing it and leaves no room for questions as to why any manufacturer or distributor would want one for their product. It does, however, come with its own set of jurisdictional limitations. In this blog, we will explore CE marking’s role, or lack thereof, in allowing a product access to the global market. Read more

Is English Sufficient for my Instructions for Use?

in Blog

Ensuring all relevant product information is communicated clearly is an extremely important part of the compliance and market entry process for medical devices. As a general rule of thumb, any information pertaining to the product and its intended use should be outlined in at least the native language of every country on the European Market it is being released to. Read more

What Needs to be Translated on a Cosmetic Label?

in Blog

The labelling process for cosmetic products is relatively straight forward, even for products seeking to enter the European Market that may be manufactured or produced outside the European Union. One of the most fundamental aspects of the labelling process to note is that a product can only be labelled and released onto the European Market after all relevant safety assessments and tests have been made and after the Notification process and work on the Product Information File has been conducted and reviewed by the Responsible Person. Though this blog will focus on the aspects a cosmetic label that need to be translated, it will also outline the other items which must be included on the label too. Read more

Do I need a CE Marking if my OEM already has one?

in Blog


Obtaining a CE Mark should be a primary target for any manufacturer seeking to introduce their product to the European Market. In many cases, CE Marking is a mandatory compliance requirement for products, and at the same time it makes the marketing of products far easier and more attractive to consumers as they are the hallmark of compliance with European harmonized standards. Read more

Cosmetic Distribution or Compliance: What comes first?

in Blog

In an effort to hold the European cosmetics market to a higher standard of user safety, EU Regulation 1223/2009/EC has laid out an extensive and detailed series of rules and guidelines governing the processes each cosmetic product must go through before they can be released onto the European Market. As each of these steps must be adhered to for the product to be allowed onto the market, it is safe to say that the Compliance Process must always precede the distribution process.

Read more

Can my Distributor act as Responsible Person

in Blog

In the field of cosmetic products, appointing a Responsible Person is a mandatory part of introducing any product to the European Market. As the Cosmetic Regulation EC 1223/2009 states: “only cosmetic products for which a legal or natural person is designated within the community as ‘responsible person’ shall be placed on the market” (Article 4.1).

Non-European companies cannot fulfil this role themselves, therefore they have to delegate this regulatory burden to another party. Many of them decide to work with one of their European distributors as Responsible Person. We must stress that this strategy is really risky and there are numerous long-term factors to take into consideration while choosing a Responsible Person: Read more

Which products fall under Personal Protective Equipment Directive PE 89/686/EEC

in Blog

The June 1995 Personal Protective Equipment directive 89/686/EEC sets out the guidelines and regulations for all personal protective equipment seeking to enter the European Market. Under the directive, ‘personal protective equipment’ is defined as “any device to be worn or held by an individual for protection against one or more health and safety hazards”. The aim of the directive is to ensure the safeguarding of public health, improve the quality of work safety, and guarantee user protection and ultimately contributes to the European Commission’s goal of facilitating free movement of quality goods throughout the European Economic Area through the use of universal Harmonized Standards. Read more

What kind of testing do I need to do to register my cosmetics in the EU?

in Blog

Product testing is an extremely important, and sometimes time consuming, part of the compliance process for a cosmetic product. It is a process that helps to prove the safety and standards of a product, which in turn facilitates the smooth compiling of the Product Information File. Fortunately, Cosmetics Regulation EC 1223/2009 helps to define each required test and what is expected of each product before it can enter the European Market. In this blog, we will outline and briefly explain the three main types of testing a cosmetics product must undergo before being registered in the EU under regulation EC 1223/2009. Read more

What is the compliance path for EMC & LVD products?

in Blog

Being aware of the compliance path for each type of device is paramount when trying to bring a wide range of products to the European market. It is down to the manufacturer to determine the applicable standards and directives that apply to a given product before identifying the appropriate conformity assessment modules relating to the product classification. After this, a ‘quality system’ of post-market surveillance, vigilance, and traceability must be conducted continuously, along with risk analysis and safety assessment reports. In short, it is a rigorous process, and one that must be given due diligence. That is why, in this blog, we are going to try to clarify the compliance process for two product categories in particular – Electromagnetic Compatibility devices and Low Voltage Devices. Read more

Do I need a Responsible Person once my products are registered on the CPNP?

in Blog

To paraphrase an adage, a Responsible Person is for life, not just for registration. The role of the Responsible Person has become absolutely crucial to almost every step of the cosmetic product manufacturing-to-distribution process. While it is true that to complete Cosmetic Product Notification Portal (CPNP) registration a Responsible Person (RP) is required, the role of the Responsible Person is far more diverse than that. In this blog, we will take a look at some of the duties the Responsible Person performs after the initial CPNP registration process and how they influence the importance of the role to the manufacturer. Read more

Basics of In-Vitro Diagnostic Medical Device Classification

in Blog

For the uninitiated, understanding the basics of In-Vitro Diagnostic Medical Devices can be a confusing process. According to the 1998 medical device directive, IVDD 98/79/EC, an in-vitro diagnostic medical device (or IVD) is defined as “any medical device which is a reagent, reagent device, calibrator, control material, kit, instrument, apparatus, equipment or system whether used alone or in combination, intended by the manufacturer to be used in-vitro for the examination of specimens including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information concerning a physiological state of health or disease or congenital abnormality or to determine the safety and compatibility with potential recipients”. In essence, IVDs are tools used in the examining of human samples (blood, urine, tissue, etc.) outside of the body. They can be used to, amongst other things, help detect infections/diseases, monitor the progress of drug therapies, and diagnose conditions.

In this blog we will try to shed some light on the IVD classification process. IVDs are classified by potential risk to the user and fall into four main groups. They are as follows:

I. All Other Devices

This is a catch-all category used to define any device or equipment that doesn’t fall into any of the below categories. Most of the devices in this group tend to be intended for professional use, rather than personal or home use.

Example: Specimen receptacles (test tube, etc.)

II. Devices for Self-Testing Not Listed in Annex II

Devices in this category are those intended for home or personal use by untrained lay persons for self-testing.

Example: Home pregnancy test

III. Device of List B, Annex II

Devices in this category are those determined for professional use posing low risk to the user.

Examples: Reagents and reagent products for the detection of infections or diseases (such as rubella or chlamydia) in humans, reagents and reagent products for determining tumoral markers (such as Prostate-Specific Antigene), or devices for the measure of blood sugar.

IV. Device of List A, Annex II

Reagents and reagent products for the detection, confirmation, and quantification in human specimens of markers of HIV infection (HIV 1 and 2), HTLV I and II (cancer causing), and Hepatitis B, C, and D.

It is very important to note that the IVDD 98/79/EC directive provides neither a specific list of affected devices, nor their corresponding classification, so the onus is on the manufacturer to determine which directives apply to which devices and proceed accordingly. The directive outlines only device requirements, as well as requirements for manufacturers, and device safety and compliance standards. Devices used in veterinary medicine or general laboratory use are not subject to directive requirements.

For more information on IVD classification, ongoing updates in the field, or advice on bringing an IVD to the European market, contact us today.

How long does it take to register a cosmetic product in the EU?

in Blog

It isn’t always easy to determine just how long it takes to register a cosmetic product for release on the European Market. In some cases it can be a lengthy process, in others quite brief.

In general, the EU compliance process takes between 4-8 months. There are two main factors determining the timeline of the registration process:

  1. How ready the technical documentation (Product Information File) is
  2. If all the safety test have been done

In order to shed some more light on this, here we will outline some of the steps in the compliance stage which are crucial to shorten the timeline of the registration process. Read more

Do I need an EAR if I have a Notified Body?

in Blog

Though both are involved in the EU Compliance process and CE Marking, a European Authorized Representative and a Notified Body are not mutually exclusive bodies. Both have roles unique to themselves throughout the EU Compliance procedure. In order to clear up a few common misconceptions regarding European Authorized Representatives (EAR) and Notified Bodies (NB), this blog will outline the definitions and roles of each in order to better further the understanding of what is required from manufacturers of certain medical devices. Read more

Why can’t my Safety Assessor act as Responsible Person?

in Blog

The role of the Responsible Person is an absolutely pivotal one in the compliance and European Market distribution process. Many questions have arisen surrounding who or what bodies may perform the functions of the Responsible Person. The most important thing to know, at any stage, is that according to EU Cosmetics Regulation (Regulation (EC) No. 1223/2009): “Only cosmetic products for which a legal or natural person is designated within the community as ‘responsible person’ shall be placed on the market”. With this in mind, it is clear that the role of the Responsible Person is one to be taken seriously, and appointments should not be made lightly – especially not to organised bodies which may have limited industry knowledge or experience, or may have a role/skillset of their own already. Read more

Third-Party Producers and the European Market

in Blog

There are many things to consider when introducing a product to the European Market for the first time. Right at the top of that list is: What is the background of my third-party producer and are there any barriers to their components entering the market?

As always, there are some steps that must be taken into consideration, especially when the manufacturers in question are themselves not located inside the European Union. In this blog, we will outline and answer some of the most pressing questions when it comes to third-party producers and the European Market. Read more

Should I work with my importer to register my cosmetic products?

in Blog

According to European Regulation EC 1223/2009 (Article 4.1), “Only cosmetic products for which a legal or natural person is designated within the community as ‘responsible person’ shall be placed on the market.” This regulation can be the cause of much confusion when it comes to appointing or working with a fitting importer in the cosmetic products field. For example, its setting out of the mandatory obligation for manufacturers to designate a European Responsible Person  – a body whose duties would otherwise fall to the (potentially uninitiated) importer – can raise many questions surrounding the effectivity of importers as regulatory representatives. We will, in this post, address some of those questions. Read more

Cosmetics Notification in the EU: A How-To Guide

in Blog

Bringing a new cosmetic product to the European market can, in the minds of some, be a long and arduous process with many hurdles to leap over along the way. While, to ensure quality and safety standards are adhered to, there are certainly factors each manufacturer must comply with, being put off or intimidated by the whole process is simply unnecessary. In this blog, we will try to put some worries to rest on the issue of notification and the European market.

Read more

What is a Medical Device according to MDD 93/42/EEC?

in Blog

After having defined and explained the Medical Device Classification System in our last blog post, it’s possible that one unexpected question has arisen – what actually is a medical device? In this blog post we will seek to answer that question.

Pining a definition to the term ‘medical device’ has never been easier since the introduction of Medical Device Directive 93/42/EEC. Introduced on June 14, 1998, and amended on September 5, 2007, the directive came into effect in March 2010 and established the essential requirements and harmonized standards for the manufacture, design, and packaging of medical devices. It is advisable, where possible, to pay close attention to the 2007 amendment as it contains an update on such industry changes as the definition of a medical device, things which are not considered a medical device, and the explanation of Member State’s role in the process. Such amendments became necessary due to rapid advancements in technology and the development of international initiatives. Read more

Basics of the Medical Device Classification System

in Blog

For many manufacturers in the industry, medical device classification can be a daunting task to say the least. Determining what device falls into what class, and what steps need to be taken afterwards to introduce the device to the European market can be difficult.

This blog will be a guide to the basics of the medical device classification system under the Medical Device Directive Annex IX and what restrictions exist at each class level.  Read more

How to Obtain a CE Mark (for a Medical Device)

in Blog

There’s a common misconception among many medical device manufacturers that obtaining a CE mark is too hard, too costly, and too complicated. We’re glad to be able to say that this isn’t true. With some knowledgeable guidance and the understanding that obtaining your CE mark is simply a process like any other, much of the undue stress and worry can be taken away.

In this blog entry we will walk through some of they key steps in obtaining a CE marking for medical devices – along with some necessary additional steps for manufacturers located outside of the European Union.

Read more

EAR for MDD I (non-measuring, non-sterile) products

in Blog

An E.A.R. or European Authorized Representative (sometimes known as an EC Rep or EC/CE Representative) is any person naturally or legally established in the European Community who is explicitly designated by the manufacturer to ensure compliance of their products. This person may be addressed by authorities and bodies within the European community, instead of the manufacturer themselves. In essence, an Authorized Representative is a legally required body for those located outside of the EU and looking to introduce medical devices to the European market.

Read more

What is the CPNP?

in Blog

The Cosmetics Products Notification Portal (CPNP) is an online notification system for submitting certain technical compliance related information about cosmetic products. It was created for the implementation of Regulation (EC) No 1223/2009 on cosmetic products and aimed at harmonizing the 28 EU Member States + 4 EFTA countries covered under this legislation. Read more

What is Eudamed?

in Blog

Eudamed is the European Databank on Medical Devices. It’s a secure, web-based portal that acts as a central hive for the exchange of information between national competent authorities and the European Commission. The portal cannot be accessed by the public. Eudamed came into force in May 2011 and was created with the purpose of strengthening market surveillance and transparency with regards to medical devices placed on the European market. Read more

Impact of the New Cosmetics Regulation

in Blog



The EU Cosmetics Regulation (Regulation (EC) No 1223/2009) has been in place for over three years since it replaced the old EU Cosmetics Directive 76/768/EEC. The regulation was introduced with the express purpose of simplifying and harmonizing the regulatory requirements across all member states while also upgrading the requirements placed on the Brand Owner. Read more

How Much Does CE Marking and Certification Cost?

in Blog

When it comes to obtaining the CE marking, one of the primary concerns for manufacturers is the financial costs involved in the process.

There are too many variables and factors to consider to be able give a uniform estimate of the costs of obtaining CE marking. However, with the right information, product manufacturers should be able to arrive at a reasonably accurate assessment of the expense involved. Read more

An Explanation of the Responsible Person

in Blog

Since the implementation of the Cosmetic Regulation EC 1223/2009 on July 11, 2013, each cosmetic product placed on the European market must now have a designated “Responsible Person”. Their job is to guarantee product compliance in front of the relevant European authorities, therefore ensuring that the product is safe for human health.

Read more

What is the CE Marking Process?

in Blog

There is a fear among many product manufacturers that the process of obtaining CE Marking is long, complicated and expensive. This blog aims to examine how much truth and validity there is to that statement.

Read more